On November 29, 2022, "It’s an excellent stent!", along with the comment of Dr. Furqon from RS Abdul Wahab Syahrani Hospital. Helios® Sirolimus-Eluting Coronary Stent from WEGO has successfully finished its first appearance and implantation in Indonesia, marking another milestone for WEGO Intervention moving forward globally. This is also solid step for WEGO Intervention to further embrace the patient worldwide.

Recently, a 54-year-old Indonesian patient was admitted to the hospital with recurrent chest pain. The hospital found that the patient was diagnosed with coronary artery disease after an angiographic examination of 80%-90% severe stenosis in the middle distal branch of the left anterior descending artery (LAD), with a lesion length of 35 mm and about 70% proximal stenosis.

To better alleviate the patient's chest pain, reduce the mortality and complications of the disease, and further improve the prognosis, Dr. Furqon prescribed a PCI approach to place coronary stents in the target vessels. During the procedure, two stents were used by Dr. Furqon during the procedure. A Helios 2.5*38 mm long stent was selected for the distal LAD to treat a diffuse long lesion, and a 4.0*16 mm stent was selected for the proximal LAD to treat a proximal LAD stenotic lesion.

"The deliverability and support of stent are excellent!" Dr. Furqon gave full credit to the performance of the Helios® stent right after the surgery. He described that the procedure was perfect as the patient's LAD vessel was dilated to normal diameter under double check by angiography, and blood flow was restored to TIMI level 3.

Established in 1944, RS Abdul Wahab Syahrani (RS AWS) is a government hospital with more than 1000 beds in the city of Samarinda, East Kalimantan, Indonesia. As a class A hospital. RS AWS is also a teaching hospital affiliated with Mulawarman University and it has the largest intracardiac interventional volume in East Kalimantan with over 3000 interventional procedures per year.

As the world's first titanium-oxygen coated cobalt-chromium alloy drug-eluting stent, Helios stent from WEGO offers the better prognostic outcomes and treatment results compared to conventional stents，greatly reduces platelet and fibrinogen adhesion and activation, inhibits inflammatory response, restores endothelial cell structure and function, and reduces metal ion release.